Viraferonpeg and lung disorder Patient Reports February 11, 2012



Viraferonpeg Side Effects Report #4682129-6
Viraferonpeg side effect was reported by a Physician from on May 24, 2005. Male patient, 73 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: lung disorder, pulmonary fibrosis What is  pulmonary fibrosis. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient recovered.

Viraferonpeg Side Effects Report #5332753-2
Viraferonpeg side effect was reported by a Physician from FRANCE on May 10, 2007. Female patient, 68 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alveolitis allergic, cryptogenic organising pneumonia, depression What is  depression, lung disorder. Viraferonpeg dosage: unknown. During the same period patient was treated with COPEGUS, PROZAC, NEXIUM. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5015160-1
Viraferonpeg side effect was reported by a Physician from FRANCE on May 18, 2006. Female patient, 54 years of age, weighting 105.8 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, cerebral ischaemia, ejection fraction decreased, leukopenia, lung disorder, pulmonary hypertension What is  pulmonary hypertension, thrombocytopenia. Viraferonpeg dosage: unknown. Patient was hospitalized. Patient died on 04/28/2006.

Viraferonpeg Side Effects Report #5719091-0
Viraferonpeg side effect was reported by a Physician from FRANCE on Apr 18, 2008. Male patient, 50 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: lung disorder. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient recovered.


Viraferonpeg Side Effects Report #4630227-5
Viraferonpeg side effect was reported by a Physician from on Mar 29, 2005. Female patient, 40 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: lung disorder. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, SUBUTEX. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5512804-2
Viraferonpeg side effect was reported by a Physician from FRANCE on Oct 29, 2007. Male patient, 39 years of age, weighting 174.2 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: arrhythmia What is  arrhythmia, disease recurrence, lung disorder, oedema peripheral, pulmonary embolism What is  pulmonary embolism, vomiting. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, PREVISCAN, ZOLOFT, OXAZEPAM. Patient died.

Viraferonpeg Side Effects Report #5888577-0
Viraferonpeg side effect was reported by a Physician from FRANCE on Sept 10, 2008. Male patient was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: ataxia What is  ataxia, lung disorder. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Viraferonpeg